test

Kenneth G. Mertz II

@Emerald Mutual Fund Advisers Trust

Latest period2024 - Q3ReportedManaged Assets$1.925BTotal holdings225
Assets growth rate0.84%Assets growth rate (2-Q avg)0.12%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Emerald Mutual Fund Advisers Trust's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 225 positions.

Assets under management

The assets under management (AUM) of Emerald Mutual Fund Advisers Trust over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.925B in assets, with a quarterly growth rate of 0.84% and a 2-quarter average growth rate of 0.12%. The portfolio is managed by Kenneth G. Mertz II, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FNFabrinet
Recent Activity
Increased 71.52%
0.86%
$16.446M
69,556 shares@ $236.45 avg price
FULTFulton Finl Corp Pa
Recent Activity
Increased 272.16%
0.82%
$15.622M
861,691 shares@ $18.14 avg price
VKTXViking Therapeutics Inc
Recent Activity
Increased 0.9%
0.81%
$15.481M
244,526 shares@ $63.31 avg price
LBPHLongboard Pharmaceuticals Inc
Recent Activity
Increased 128.5%
0.73%
$13.981M
419,462 shares@ $33.33 avg price
XPROExpro Group Holdings Nv
Recent Activity
Increased 64.66%
0.66%
$12.69M
739,080 shares@ $17.18 avg price
PTLOPortillos Inc
Recent Activity
Increased 11.79%
0.63%
$12.116M
899,461 shares@ $13.48 avg price
EVEREverquote Inc
Recent Activity
Increased 572.14%
0.56%
$10.631M
504,081 shares@ $21.09 avg price
ACADAcadia Pharmaceuticals Inc
Recent Activity
Increased 2.86%
0.46%
$8.841M
574,810 shares@ $15.39 avg price
CLDXCelldex Therapeutics Inc
Recent Activity
Increased 92.03%
0.44%
$8.287M
243,795 shares@ $33.99 avg price
BPOPPopular Inc
Recent Activity
Increased 84.3%
0.4%
$7.571M
75,509 shares@ $100.27 avg price